The identification of identical MED12 p.G44D mutations in both tumor types confirms a shared molecular origin, establishing disruption of the Mediator kinase module as a common vulnerability in hormone-responsive mesenchymal tissues. This evidence concerns the gene MED12 and neoplasm.